🇬🇧 Beta-D-N4-Hydroxycytidine in United Kingdom

Beta-D-N4-Hydroxycytidine (MOLNUPIRAVIR) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Lagevrio
  • Status: approved

Beta-D-N4-Hydroxycytidine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United Kingdom

Frequently asked questions

Is Beta-D-N4-Hydroxycytidine approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Beta-D-N4-Hydroxycytidine in United Kingdom?

Msd K.K. is the originator. The local marketing authorisation holder may differ — check the official source linked above.